SEC FILE NUMBER: 000-30239

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

     (Check One): [ ] Form 10-K and Form 10-KSB [ ] Form 11-K [ ] Form 20-F
                  [X] Form 10-Q and Form 10-QSB [ ] Form N-SAR

                  For Period Ended: September 30, 2004
                  [  ] Transition Report on Form 10-K
                  [  ] Transition Report on Form 20-F
                  [  ] Transition Report on Form 11-K
                  [  ] Transition Report on Form 10-Q
                  [  ] Transition Report on Form N-SAR
                  For the Transition Period Ended:
                                                  ------------------------------

  Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
    Nothing in this form shall be construed to imply that the Commission has
                   verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

________________________________________________________________________________

PART I - REGISTRANT INFORMATION

AMEXDRUG CORPORATION
- -------------------------------------------------------------------------------
Full Name of Registrant


- -------------------------------------------------------------------------------
Former Name if Applicable

8909 West Olympic Boulevard, Suite 208
- -------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Beverly Hills, California 90211

- -------------------------------------------------------------------------------
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

          (a)  The reasons  described in  reasonable  detail in Part III of this
               form  could  not be  eliminated  without  unreasonable  effort or
               expense;

          (b)  The subject annual report,  semi-annual report; transition report
               on Form 10-K, Form 20-F,  11-K,  Form N-SAR, or portion  thereof,
               will be filed on or before the  fifteenth  calendar day following
[x]            the  prescribed  due date;  or the  subject  quarterly  report of
               transition  report on Form 10-Q, or portion thereof will be filed
               on or before the fifth  calendar day following the prescribed due
               date; and

          (c)  The accountant's statement or other exhibit required by Rule
               12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable  detail the reasons why the Form 10-K,  10-KSB,  11-K,
20-F, 10-Q,  10-QSB,  N-SAR, or the transition report or portion thereof,  could
not be filed within the prescribed time period. (Attach Extra Sheets If Needed)





         The quarterly  report of Amexdrug  Corporation on Form 10-QSB could not
         be filed on time because management requires additional time to compile
         and verify the data  required to be included in the report.  The report
         will be filed within five calendar days of the date the original report
         was due.

PART IV - OTHER INFORMATION

(1)      Name and  telephone  number  of  person  to  contact  in regard to this
         notification

           Robert N. Wilkinson   (801)           533-9645
         ---------------------   -----     ---------------------
                (Name)        (Area Code)   (Telephone Number)

(2)      Have all other periodic  reports  required under Section 13 or 15(d) of
         the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
         Company  Act of 1940  during  the  preceding  12  months  (or for  such
         shorter)  period that the registrant was required to file such reports)
         been filed? If answer is no, identify report(s).         [x] Yes [ ] No

(3)      Is it anticipated that any significant  change in results of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected  by the  earnings  statements  to be  included in the subject
         report or portion thereof?                               [x] Yes [ ] No

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
         narratively and quantitatively,  and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

         Amexdrug Corporation  anticipates reporting net income of approximately
         $149,000 for the fiscal quarter ended September 30, 2004 as compared to
         net income of $34,748  reported for the fiscal quarter ended  September
         30, 2003.

- --------------------------------------------------------------------------------


                              Amexdrug Corporation
                           -------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.


Date   November 15, 2004    By /s/ Jack Amin
     -------------------      -------------------------------------------------
                              Jack Amin, President and Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

       Intentional Misstatements or omissions of fact constitute Federal
                    Criminal Violations (See 18 U.S.C.1001).


SEC/0544